India's drug regulator approved Covovax for restricted use in emergency situations in adults on December 28 and in children in the 12-17 age group, subject to certain conditions, on March 9.
Covid vaccine Covovax s inclusion in the vaccination programme for the 12-17 years age group has been recommended by the Covid-19 Working Group, official sources said on Sunday.The Central Drugs Standard Control Organisation s Subject Expert .
India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12-17 age group, subject to certain conditions, on March 9.
India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12-17 age group, subject to certain conditions, on March 9.